Immunotoxicology is a science which deals with the effects of physical and chemical agents and other toxic substances on the immune system. The discipline includes study of the detection, occurrence, adverse effects, and mechanisms of chemically-induced immune dysfunction. Many drugs and chemicals are known to compromise the immune response of a host which is extremely vulnerable and sensitive to perturbation by these agents. The consequences of immune dysfunction may be expressed in reduced resistance to infectious and neoplastic diseases, or enhanced hypersensitivity and autoimmunity. The immunomodulating profiles of xenobiotics may be diverse, involving several components of the immune system, or they may selectively compromise an individual compartment of the immune response. Many drugs and chemicals are known to result in immune disregulation in animals, but a paucity of information is available to indicate the effects of xenobiotics on systemic immunity in humans. Epidemiological studies and research designed to assess chemical immunomodulation in man are necessary to confirm animal data. Further, a definitive diagnosis for chemically-induced immune dysfunction must include several etiologies and body organ systems, since a triad of reciprocal interactions exists between the immune, endocrine, and central nervous systems.
INTRODUCTION
The Fifth International Symposium of the Society of Toxicologic Pathologists focused on immunotoxicology/pathology of the immune system. Topics included structure and function of the immune system, an introduction to immunotoxicology and immunopharmacology, and discussions of the mechanisms and tissue responses of xenobiotics, drugs, and environmental chemicals, autoimmune mechanisms, in vivo and in vitro methods, mechanisms of hypersensitivity, cytokine responses, and the pathologist's role in assessing immunotoxicity. Scientists from throughout the world congregated to discuss technological advances and the current state of a relatively new discipline, immunotoxicology.
The structure, function, and purpose of the intact immune system were discussed. The immune system can be divided into innate and specific responses aimed at protecting the host against disease. Innate responses are inherited and present at birth, while specific responses refer to learned responses that are generally acquired before or during adolescence. In addition, many drugs and chemicals selectively compromise an individual compartment of the immune response or subpopulation of immunocytes * Presentedat the Fifth InternationalSymposiumoftheSociety of Toxicologic Pathologists: "The Immune System-Toxicology/ Pathology," May 18-2 1, 1986, Chicago, Illinois. (Table I) . For instance, corticosteroids impair helper T (HT) lymphocytes (21) (22) (23) , while cyclosporin A impairs the functional capacity of the T cell lineage mediated by interference of the interleukin 2 (IL2) surface receptor (1 3) (Table I) . Cyclophosphamide, on the other hand, has a preferential toxicity for actively proliferating cells, and affects B cells more than T cells (24, 25) .
Polychlorinated biphenyls suppress almost all major compartments of the immune system (6, 10, 15, 17) , whereas pentachlorophenol decreases the action of B and T lymphocytes as it simultaneously increases macrophage activity (1 1). Toxaphene inhibits B cell and macrophage function, while sparing the T cell (1). Excess selenium suppresses B cell, T cell, and macrophage activity, while stimulating natural killer cell (NKC) cytotoxicity (15, 18 IMMUNOTOXICOMGY Immunotoxicology as a discipline was spawned in the early 1970s, and is currently a concern of toxicologists, immunologists, medical professionals, and other scientists who recognize that chemicals can induce immune dysfunction in both animals and man. The consequence of immune dysfunction is either increased susceptibility to infections and neoplastic disease, or hypersensitivity and autoimmunity. Because these effects frequently occur at low levels of exposure in the absence of overt toxicity (subclinical), they often remain unrecognized as a contributor in these disease processes. Therefore, it is of considerable public health concern to be able to accurately and definitively identify substances which alter immunity.
Immunotoxicology, as a science, deals with the effects of physical and chemical agents and other toxic substances on the immune system. It includes study of the detection, occurrence, adverse effects, and mechanisms of chemical-induced immune disregulation. Immunopharmacology parallels this discipline, but deals predominantly with drugs and biological response modifiers. Both fields are rapidly expanding because of the ubiquitous spread of chemicals in the environment and the widespread use of drugs that can potentially impact the immune responsiveness of humans.
The immune system is highly intraregulated by a networking circuitry composed of immunocytes and their secretory products. For example, antigens trigger local chemical signals, which in turn trigger a network of responding cells operative throughout the body. A typical cascade of immune events following antigenic stimulation would be initial expression of Ia molecules on the surface of macrophages, which activates the production of interleukin 1 (ILI). This in turn activates T lymphocytes to produce IL2 which is responsible for the proliferation of HT cells which in turn activate B lymphocytes to differentiate into antibody-producing plasma cells or memory B lymphocytes. Disruption of any,one of these processes can impede the immunologic process. While the immune system is considered to be somewhat autonomous in both regulation and action, recent data suggests that a significant reciprocal interaction occurs between the nervous, endocrine, and immune systems (2-4, 19) . For example, some classical neuroendocrine hormones and neurotransmitters possess immunomodulatory activity, while immunocytokine hormones share common receptors with the central nervous systems and function as endocrine glands (3,4). Thus, a putative nervousendocrine-immune axis is formed, which further complicates assessment of systemic immune reactivi ty.
Several immunological methods have been developed in rodent models to assess immune dysfunction which results from exposure to xenobiotics. The assays are highly sensitive, quantitative, reproducible, and occasionally automated. Several animal species, particularly the mouse, rat, and guinea pig, have been utilized as the animal of choice. Future investigations will refine these techniques and apply newly developed biotechnology for the advancement of immunotoxicology.
MECHANISMS OF IMMUNE TOXICITY The immune system is extremely vulnerable and sensitive to modulation by drugs and chemicals. It is a rapidly proliferating and differentiating target organ system, composed of numerous cell types that are regulated by a network of cellular components and soluble factors which represent several organ systems. In addition, immunocytes are exposed to chemicals and their metabolites in the circulatory system, organs, tissues, and cells, as well as in extracellular fluids. Therefore, exposure to drugs and chemicals can be continuous rather than brief, regardless of distribution. Chemicals can react with cell membranes, receptors, or internal structures, and interfere with other regulatory systems in the network of immune events. Escape of the immune system from exposure to these exogenous agents is nearly impossible.
As mentioned previously, many chemicals may differentially affect the cascade of immune events by affecting different lineages or, more selectively, specific subsets of the same population of cells. These agents may also evoke a different effect on a particular function ofa multifunctional immunocyte. Further, it is not unusual to expect specific dose responses, rather than a typical linear dose response, following exposure to chemicals, since different sensitivities among cells in the immune circuitry are regulatory and functional at different levels in the sequence of the immune event. These factors are extremely important when interpreting immune assessment following exposure of cells to chemicals in tissue culture. The sophistication of the immune system has not permitted duplication or assimilation of an intact system in vitro.
The consequences of immune dysfunction are either immunosuppression, which can reduce host resistance to infections and neoplastic disease, or immunoenhancement, which can provoke hypersensitivity and autoimmunity. Hypersensitivity responses can be classified into four major types: Types I, 11, and I11 (which are termed "immediate"), and Type IV, which is a delayed-type hypersensitivity (DTH). The first three types are antibody-mediated reactions, while the DTH is characteristic of cellmediated immunity and is elicited by T lymphocytes in the absence of antibody.
Contact hypersensitivity is a form of DTH. This condition is not life-threatening, but it results in various degrees of discomfort. DTH responses are controlled by accessory cells and suppressor T lymphocytes (5, 14). Macrophages secrete numerous monokines, which affect proliferation and differentiation of all T cell subsets. Thus, classical DTH reactions are dependent upon an intricate network of cells and their secretory products, which regulate the intensity of the DTH effector T lymphocytes. Drugs and chemicals may alter the magnitude of this response at several points in the pathway.
ASSESSMENT OF IMMUNOTOXICITY
A myriad of assays is available to assess the integrity of the immune system, both in vivo and in vitro. The consensus of most immunotoxicologists is that a panel of immunoassays should include procedures for assessing humoral immunity, cell-mediated immunity (CMI) macrophage function, pathotoxicologic examination of lymphoid tissues, and host resistance to an infectious and/or oncogenic agent. This paradigm has recently been expanded to include NKC cytotoxicity and production/activity of numerous regulatory cytokines. , Multi-tiered approaches have been developed by several laboratories to ascertain the immunotoxic potential of drugs and chemicals. The initial tier generally includes fundamental procedures for assessing the major components of the immune system. Additional tiers are organized to evaluate in more detail those compartments of the immune response which are identified in tier one for alteration by the test agent. In our laboratory, a rat model has been developed in which seven individual immune functions, many of which are dependent upon each other for optimum function, can be assessed in a single animal (1 2). This feature minimizes animalto-animal and day-to-day variation, reduces experimental and comparative error, and is extremely economical. The model evaluates hormonal immunity, CMI, NKC, and ILl, IL2, PGE, and interferon activity (Table 11) . Thus, a relatively comprehensive immune profile for a drug or chemical can Although exposure ofanimals in vivo to drugs and chemicals is preferable, assessment of immune response in vitro offers certain advantages. The cellular components of the immune system can be dissected to elucidate the specific cell type(s) that predominate and interact for optimum responses. Cells can be sensitized and stimulated in culture with numerous antigens and mitogens, and the ensuing responses can be easily calibrated. In addition, the reaction of a variety of immune cells and/or their secretory products can be objectively evaluated under a spectrum of different combinations. In this type of system, cell interactions can be delineated and even manipulated in order to identify and explore cellto-cell interactions.
The immune events cannot only be manipulated in culture, but can also be assessed for chemical dysregulation by drugs and other chemicals. Chemicals can be added directly to immune cells in culture to evaluate effects on individual cell populations.
However, it is important to remember that with the possible exception of metals, most chemicals are usually metabolized within the body, and it is the metabolite, rather than the original chemical, that may be the immunotoxicant. Further, metals could bind to surface proteins in a different manner or in higher concentrations than would be expected to occur in vivo. Thus, results obtained iij vitro should be regarded with reservations when generalizing to responses of an intact animal system.
TISSUE RESPONSES IN THE IMMUNE SYSTEM
Xenobiotics are defined as pharmacologically, endocrinologically, or toxicologically active substances that are not endogenously produced, and are therefore foreign to an organism. This definition includes drugs and industrial and other environ-of these agents are also transferred across the putative blood-brain and placental barriers. Thus, only infrequently may a cell, tissue, organ, or even the embryo and developing fetus be spared from ex-posure.
The lymphoid system is essentially dispersed throughout the body; it can be examined grossly at necropsy and by comparison of orgadbody weight ratios. Microscopically, the thymus, bone marrow, spleen, lymph nodes and mucosa-associated lymphoid tissue can be examined by routine staining procedures or by special stains and immunocytochemical technology. Morphometric evaluation is also a valuable resource in assessment of xenobioticinduced immune dysfunction. Flow cytometry is another approach for ascertaining the mechanism by which these agents are immunotoxic. The central nervous system (CNS) can either orchestrate the immune response or be a target organ of immunological disease. As presented in this symposium, immunocytes are active within the CNS to combat disease. Some of these reactive cells are transported into the brain via circulation, while others are local residents. However, the blood-brain barrier can restrict movement of immunocytes and protein from the blood into the CNS.
The immune system may also be responsible for certain diseases of the CNS. For example, a large percentage of patients with multiple sclerosis (MS) have defective interferon production and impaired NKC activity (26) . Further, monocytes from MS patients produced larger amounts of prostaglandin E (PGE), and leukocytes from affected individuals are more sensitive to PGE than are those from normal subjects (7). Thus, these data support the hypothesis that the etiology of MS may, at least in part, be mediated by the immune system. The sharing of surface receptors for products secreted by the CNS and immune system confirm that interrelationships exist between these two systems.
PERSPECTIVES IN IMMUNOMODULATION
Humoral immunity is expressed by B lymphocytes which differentiate into plasma cells that syn-TOXICOLOGIC PATHOLOGY thesize and secrete antibody into the circulation. Antibody can be easily enumerated by several acceptable techniques. Two of these in particular, radioimmunoassay and enzyme-linked immunoabsorbent assays, are quantitative, and possess an extremely high degree of sensitivity. Many compounds representing several classes ofchemicals have compromised immunity in several species of animals. Some of these agents are lead, cadmium, tetrachlorodibenzodioxin, polychlorinated biphenyl, pentachlorophenol, benzo(a)pyrene, dimethylbenz(a)anthracene, urethane, toxaphene, chlorine dioxide, 2,4-dichlorophenol, and diethylnitrosamine (16) . The humoral immune response appears to be extremely sensitive for detecting chemical dysregulation, since the majority of immunotoxic chemicals suppress humoral immune responses. Nevertheless, the humoral response is regulated by other components (T lymphocyte and macrophages) of the immune network.
Cell-mediated immunity (CMI) is characterized by T cells that are composed both of effector and regulator subpopulations. The test most widely accepted by immunotoxicologists as representative of CMI consists ofvanous modifications of DTH. Some chemicals known to suppress DTH are lead, tetrachlorodibenzodioxin, carbofuran, 2,4-dichlorophenol, diethylnitrosamine, and dialkyltin (1 6).
Chemicals that compromise the phagocytic index of macrophages include lead, cadmium, nickel, pentachlorophenol, and toxaphene. Other agents, such as selenium, diethylnitrosamine, chlorine dioxide, and monochloramine, affect monokine production or activity (1 6). Lymphokines are altered by chemicals such as lead, manganese, polychlorinated biphenyl, and chlorine dioxide (1 6). Natural killer cells also are affected by chemicals. Some of these include polychlorinated biphenyl, chlorine dioxide, selenium, ethylnitrosourea, methylcholanthrene, manganese, and nickel (16) .
Selected chemicals, including polychlorinated biphenyl, polybrominated biphenyl, lead, nickel, cobalt, zinc, and selenium, are known to modulate immunity in humans (1 6). Continued epidemiological and experimental investigations in man will no doubt expand this list. Thus, since humans are susceptible to the immunotoxic properties of xenobiotics, health officials must be aware that selected agents may be detrimental to health by methods other than standard established toxicological parameters.
In summary, immunotoxicology has made marked advances in the past decade. Highly sensitive, quantitative, reproducible immunoassays have been developed and adapted to detect immunomodulation by drugs and chemicals. Numerous xenobiotics have been discovered that compromise immunity, frequently at extremely low dosages, while they do not incite other toxicologic signs or symptoms. The reaction may alter several components of the immune system or target a single compartment or subpopulation of cells. These features, whether suppressive or stimulatory, may be detrimental to the host and may be manifested by several types of immunologically related syndromes. The pathologist can engage in assessment of immunotoxicity by routine procedures, both at necropsy and through histopathological methods. However, immunocytochemical and morphometric techniques provide a powerful tool to the pathologist, not only for diagnostic purposes, but also for objectively searching for the underlying mechanism by which xenobiotics mediate immune dysregulation.
